Clinical Trial Update: Evaluating the Safety and Immunogenicity of MTBVAC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and immunogenicity of MTBVAC in people with HIV infection and tuberculosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• MTBVAC

Snippet

Sponsor: HIV Vaccine Trials Network | Conditions: HIV I Infection, Tuberculosis | Phase 2 | Status: RECRUITING